Homology Medicines

Homology Medicines

A genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases.

Homology Medicines is a genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases. Founded 2015 in Lexington, Massachusetts, United States by Laura Smith and Saswati Chatterjee, Homology’s proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders. The company has a suite of 15 AAVHSC patents, including a proprietary gene editing and gene therapy platform for rare diseases.

The company has developed a novel set of adeno-associated virus vectors derived from human hematopoietic stem cells (AAVHSCs) that are designed to precisely and efficiently deliver genetic medicines in vivo either through gene therapy or by harnessing the body’s natural DNA repair process of homologous recombination through nuclease-free gene editing.

Timeline

2015

Founded

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Homology Medicines Inc funding round, August 2017
83,500,000
August 2017
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Laura Smith

Scientific Co-founder & Project Lead Scientist

Saswati Chatterjee

Co-Founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.